Page last updated: 2024-11-04

sulfadiazine and Disbacteriosis

sulfadiazine has been researched along with Disbacteriosis in 2 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Collinet, A1
Grimm, P1
Jacotot, E1
Julliand, V1
Zhang, ML1
Li, WX1
Wang, XY1
Wu, YL1
Chen, XF1
Zhang, H1
Yang, LQ1
Wu, CZ1
Zhang, SQ1
Chen, YL1
Feng, KR1
Wang, B1
Niu, L1
Kong, DX1
Tang, JF1

Other Studies

2 other studies available for sulfadiazine and Disbacteriosis

ArticleYear
Biomarkers for monitoring the equine large intestinal inflammatory response to stress-induced dysbiosis and probiotic supplementation.
    Journal of animal science, 2022, Oct-01, Volume: 100, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Biomarkers; Dietary Supplements; Dysbiosis; Fatty Acids; H

2022
Oxymatrine ameliorates experimental autoimmune encephalomyelitis by rebalancing the homeostasis of gut microbiota and reducing blood-brain barrier disruption.
    Frontiers in cellular and infection microbiology, 2022, Volume: 12

    Topics: Animals; Blood-Brain Barrier; Dysbiosis; Encephalomyelitis, Autoimmune, Experimental; Gastrointestin

2022